The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...